ROYAL BANK OF CANADA - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,514,000
-64.7%
118,664
-15.5%
0.00%
-66.7%
Q2 2023$12,797,000
+41.4%
140,485
+2.4%
0.00%0.0%
Q1 2023$9,053,000
+69.4%
137,243
+32.8%
0.00%
+50.0%
Q4 2022$5,343,000
+5.4%
103,316
+39.2%
0.00%0.0%
Q3 2022$5,069,000
+36.4%
74,219
-9.7%
0.00%
+100.0%
Q2 2022$3,716,000
-18.5%
82,172
-8.5%
0.00%0.0%
Q1 2022$4,562,000
-8.3%
89,782
-14.6%
0.00%0.0%
Q4 2021$4,973,000
+64.3%
105,190
+14.5%
0.00%0.0%
Q3 2021$3,027,000
-44.1%
91,881
+7.3%
0.00%0.0%
Q2 2021$5,414,000
+43.8%
85,649
-2.4%
0.00%0.0%
Q1 2021$3,766,000
-21.3%
87,773
+4.9%
0.00%0.0%
Q4 2020$4,785,000
+72.2%
83,669
-9.1%
0.00%0.0%
Q3 2020$2,778,000
+17.3%
92,065
+27.0%
0.00%0.0%
Q2 2020$2,368,000
+19.0%
72,497
-2.4%
0.00%0.0%
Q1 2020$1,990,000
-15.1%
74,282
-2.9%
0.00%0.0%
Q4 2019$2,343,000
+27.0%
76,508
-0.1%
0.00%0.0%
Q3 2019$1,845,000
-15.3%
76,595
-10.8%
0.00%0.0%
Q2 2019$2,177,000
+23.6%
85,896
-4.9%
0.00%0.0%
Q1 2019$1,762,000
+72.9%
90,367
+16.9%
0.00%
Q4 2018$1,019,000
+16.5%
77,275
+56.9%
0.00%
Q3 2018$875,000
+589.0%
49,242
+757.6%
0.00%
Q2 2018$127,0005,742
+287000.0%
0.00%
Q1 2018$0
-100.0%
2
-98.0%
0.00%
Q4 2017$2,000980.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders